Information in the media
The information published in the media on 22 February 2023 abaut the plans of AB Rokiskio suris for 2023 are only
Globe Newswire23-02-2023, 14:28
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe 22-05-2024, 12:00